» Articles » PMID: 20421935

Simulating Microdosimetry in a Virtual Hepatic Lobule

Overview
Specialty Biology
Date 2010 Apr 28
PMID 20421935
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The liver plays a key role in removing harmful chemicals from the body and is therefore often the first tissue to suffer potentially adverse consequences. To protect public health it is necessary to quantitatively estimate the risk of long-term low dose exposure to environmental pollutants. Animal testing is the primary tool for extrapolating human risk but it is fraught with uncertainty, necessitating novel alternative approaches. Our goal is to integrate in vitro liver experiments with agent-based cellular models to simulate a spatially extended hepatic lobule. Here we describe a graphical model of the sinusoidal network that efficiently simulates portal to centrilobular mass transfer in the hepatic lobule. We analyzed the effects of vascular topology and metabolism on the cell-level distribution following oral exposure to chemicals. The spatial distribution of metabolically inactive chemicals was similar across different vascular networks and a baseline well-mixed compartment. When chemicals were rapidly metabolized, concentration heterogeneity of the parent compound increased across the vascular network. As a result, our spatially extended lobule generated greater variability in dose-dependent cellular responses, in this case apoptosis, than were observed in the classical well-mixed liver or in a parallel tubes model. The mass-balanced graphical approach to modeling the hepatic lobule is computationally efficient for simulating long-term exposure, modular for incorporating complex cellular interactions, and flexible for dealing with evolving tissues.

Citing Articles

A liver digital twin for in silico testing of cellular and inter-cellular mechanisms in regeneration after drug-induced damage.

Zhao J, Ghallab A, Hassan R, Dooley S, Hengstler J, Drasdo D iScience. 2024; 27(2):108077.

PMID: 38371522 PMC: 10869925. DOI: 10.1016/j.isci.2023.108077.


Mesoscale visualization of three-dimensional microvascular architecture and immunocyte distribution in intact mouse liver lobes.

Liu Z, Xu M, Huang S, Pan Q, Liu C, Zeng F Theranostics. 2022; 12(12):5418-5433.

PMID: 35910800 PMC: 9330531. DOI: 10.7150/thno.71718.


A computational model of liver tissue damage and repair.

Adhyapok P, Fu X, Sluka J, Clendenon S, Sluka V, Wang Z PLoS One. 2020; 15(12):e0243451.

PMID: 33347443 PMC: 7752149. DOI: 10.1371/journal.pone.0243451.


The liver, a functionalized vascular structure.

Lorente S, Hautefeuille M, Sanchez-Cedillo A Sci Rep. 2020; 10(1):16194.

PMID: 33004881 PMC: 7531010. DOI: 10.1038/s41598-020-73208-8.


Virtual Lobule Models Are the Key for Multiscale Biomechanical and Pharmacological Modeling for the Liver.

Ho H, Zhang E Front Physiol. 2020; 11:1061.

PMID: 32982791 PMC: 7492636. DOI: 10.3389/fphys.2020.01061.


References
1.
Ito K, Houston J . Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm Res. 2004; 21(5):785-92. DOI: 10.1023/b:pham.0000026429.12114.7d. View

2.
Liu L, Pang K . An integrated approach to model hepatic drug clearance. Eur J Pharm Sci. 2006; 29(3-4):215-30. DOI: 10.1016/j.ejps.2006.05.007. View

3.
Hartung T . Toxicology for the twenty-first century. Nature. 2009; 460(7252):208-12. DOI: 10.1038/460208a. View

4.
Judson R, Richard A, Dix D, Houck K, Martin M, Kavlock R . The toxicity data landscape for environmental chemicals. Environ Health Perspect. 2009; 117(5):685-95. PMC: 2685828. DOI: 10.1289/ehp.0800168. View

5.
Pang K, Rowland M . Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm. 1977; 5(6):625-53. DOI: 10.1007/BF01059688. View